At the Extra General Meeting held in Biotage AB (Reg. No. 556539-3138) on November 7, 2019, the following resolutions were passed, among others. Determination of the number of members of the Board of Directors The extra general meeting resolved in accordance with the Nomination Committee proposal that the Board of Directors shall consist of six […]
Remy Evard and Chris Lynch join Executive Chairman, Patrick Grady, on TetraScience Board BOSTON — TetraScience, developers of the industry’s first cloud-based data integration platform for life sciences R&D, today announced the election of Remy Evard, former CIO at the Novartis Institutes for BioMedical Research (NIBR), and Christopher Lynch, distinguished tech executive and venture capitalist, to its board of […]
Cambridge, United Kingdom – Congenica Ltd, a pioneering digital health company enabling accelerated interpretation of complex genomic data to improve disease characterization and diagnosis, has announced the appointment of Dr Heiner Dreismann as non-executive Director and Senior Independent Director on the board. Heiner has over 35 years’ experience in the global leadership of high-growth life […]
SEATTLE–NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced the appointment of Don Kania, Ph.D. to its board of directors, effective October 30, 2019. “Dr. Kania has spent his entire career developing and commercializing leading-edge technologies, so he is a great cultural fit for […]
HOLLISTON, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that Yash Singh has been named Executive Vice President, Cellular & Molecular Technologies, reporting to Chairman, President and CEO, Jim Green. Singh will lead the newly formed Cellular and Molecular Technologies (CMT) team, which combines the former PCMI and Electro-Physiology teams into a larger scale business which […]
Männedorf, Switzerland – The Tecan Group (SIX Swiss Exchange: TECN) announced today that Ralf Griebel has been appointed a member of the Management Board and Head of the Partnering Business division. He will assume his new position at Tecan no later than May 1, 2020. Until then, Achim von Leoprechting, CEO of Tecan, will continue to […]
INDIANAPOLIS — Roche Diagnostics Corporation (RDC), part of the Roche Group (SIX: RO, ROG;OTCQX: RHHBY), today announced the appointment of Matthew Sause as President and Chief Executive Officer, North America, effective November 4, 2019. The position is based at RDC’s North American headquarters in Indianapolis. Sause joins Roche Diagnostics from Gilead Sciences, where he was Senior Vice President and Head of […]
SAN FRANCISCO–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Nicolas M. Barthelemy to its board of directors. Mr. Barthelemy brings extensive experience, both as an operational executive and board member, in the areas of biopharmaceutical, life […]
CALGARY – Nanalysis Scientific Corp. (the “Company” or “Nanalysis“, TSX-V: NSCI), is pleased to announce that Luke Caplette is joining the company as its Chief Financial Officer (CFO). Mr. Caplette, CPA/CA, spent the early part of his career at Ernst & Young as Senior Accountant and was most recently CFO at Cordy Oilfield Services Inc. Luke Caplette states: “I am excited to […]
Ghent, Belgium – PharmaFluidics NV, an innovative player in the field of proteomics with the unique high-resolution µPACᵀᴹ micro-Chip chromatography products, is pleased to welcome Prof. Dr. Matthias Mann as member of its Advisory Board. Prof. Dr. Matthias Mann is a pioneer, eminent researcher and global authority in the field of proteomics. With his research […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
